跳至主要内容
临床试验/NCT01615926
NCT01615926终止不适用

Assessment of The Clinical Course of Dyspnea and Its Association With Respiratory Rate in Patients With Acute Heart Failure Syndromes

Northwestern University1 个研究点 分布在 1 个国家目标入组 16 人开始时间: 2012年6月最近更新:
适应症

试验速览

阶段
不适用
状态
终止
入组人数
16
试验地点
1
主要终点
To determine the association between respiratory rate and self-reported dyspnea in AHF patients.

研究概览

简要总结

Acute heart failure (AHF) is defined as a gradual or rapid change in heart failure (HF) signs and symptoms, such as shortness of breath (also called dyspnea or breathlessness), leg swelling, fatigue, breathlessness with exertion, trouble sleeping flat at night, and weight gain resulting in a need for urgent therapy. AHF results in over 1 million hospitalizations every year, resulting in an enormous public health burden. Approximately 1/3rd of patients will either be re-hospitalized or die within three months, and the resultant financial costs are large. As such, improving outcomes for AHF patients is critically important. Shortness of breath is the most common reason why patients with AHF present to the ER. As such, understanding how severe this symptom is, how much it improves with current treatments is very important to both patients and physicians. The purpose of this study is to determine the degree to which your shortness of breath improves during the first few days of hospitalization and its association with how fast you are breathing.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Male or female ≥ 18 years of age
  • AHFS is the primary working diagnosis for ER management and treatment with planned admission
  • Have received IV diuretic therapy
  • Enrolled within 3 hours of initial diuretic dose

排除标准

  • BNP level is ≤ 300 pg/mL (may be initially enrolled and then will be excluded for second assessment)
  • Transplant recipients of any kind
  • Fever > 101.5
  • Severe lung disease (required home O2 or daily oral steroids)
  • Any ACS event within last 30 days
  • Life expectancy less than 12 months for any reason
  • Current treatment for any malignancy of any kind
  • Cardiogenic shock and/or requiring IV inotropic therapy
  • Pregnant or recently pregnant within last 90 days
  • Inability to give appropriate written consent

结局指标

主要结局

To determine the association between respiratory rate and self-reported dyspnea in AHF patients.

时间窗: 24 hours

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Peter Pang

Associate Professor of Emergency Medicine

Northwestern University

研究点 (1)

Loading locations...

相似试验